Sweden

#ECTRIMS2016 – Cognitive Problems in MS Patients Linked to Lower Income, Study Reports

In a recent talk, titled ā€œIncome and cognitive impairment among multiple sclerosis patients,ā€ scientists investigated how cognitive impairmentĀ impacts the life of patients with multiple sclerosis (MS), and reported significant differences in incomeĀ that correlated with levels of MS-cognitive deficit. These findingsĀ were recently presented at the 32nd Congress of theĀ European Committee for…

Lymphoma Drug, Rituximab, Highly Effective in Treating Relapsing MS, Study from Sweden Reports

Mabthera (rituximab), a widely approved drug for treating lymphoma and/or rheumatoid arthritis, is highly effective in treating multiple sclerosis (MS), researchers reported in an observational study in Sweden, where Mabthera is increasingly being used outside of its approved indications to treat relapsing-remitting MS patients. The study, published in the journal…